Panagora Asset Management’s Aclaris Therapeutics ACRS Stock Holding History

Panagora Asset Management’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.17M	Buy	1,356,152 +853,862	+170%	+$3.81M	0.02%	396
2026 Q1	$1.88M	Buy	502,290 +434,100	+637%	+$1.46M	0.01%	597
2025 Q4	$205K	Buy	68,190 +22,605	+50%	+$57.1K	﹤0.01%	1123
2025 Q3	$86.6K	Buy	+45,585	New	+$79.5K	﹤0.01%	1135
2021 Q3	–	Sell	-749	Closed	-$13K	–	1706
2021 Q2	$13K	Sell	749 -25	-3%	-$568	﹤0.01%	2213
2021 Q1	$20K	Hold	774	–	–	﹤0.01%	2308
2020 Q4	$5K	Buy	+774	New	+$3.27K	﹤0.01%	2444
2020 Q2	–	Sell	-57,155	Closed	-$59K	–	2555
2020 Q1	$59K	Buy	+57,155	New	+$77.8K	﹤0.01%	1847

Other funds holding ACRS

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Panagora Asset Management's ACRS Position: Q2 2026 in Review

Panagora Asset Management increased its Aclaris Therapeutics (ACRS) stake by 170% in Q2 2026, buying an estimated $3.81M and bringing the position to 1,356,152 shares worth $7.17M. The position accounts for 0.02% of the portfolio, ranked #396.

Panagora Asset Management first reported a position in ACRS in Q1 2020 and has held it in 8 quarters since. 148 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

Panagora Asset Management held 1,356,152 shares of Aclaris Therapeutics worth $7.17M as of Q2 2026.
Panagora Asset Management bought 853,862 Aclaris Therapeutics shares in Q2 2026, an estimated $3.81M.
Aclaris Therapeutics made up 0.02% of Panagora Asset Management's portfolio in Q2 2026, its #396 holding.
Panagora Asset Management first reported a position in Aclaris Therapeutics in Q1 2020 and has held it in 8 quarters since.
148 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.